APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 177 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $143,585,000 | +99.9% | 2,271,917 | +35.7% | 0.63% | +102.9% |
Q1 2021 | $71,832,000 | +40.1% | 1,674,004 | +86.7% | 0.31% | +61.1% |
Q4 2020 | $51,283,000 | +89.6% | 896,551 | 0.0% | 0.19% | +78.7% |
Q3 2020 | $27,049,000 | -7.6% | 896,551 | 0.0% | 0.11% | -16.3% |
Q2 2020 | $29,281,000 | +21.9% | 896,551 | 0.0% | 0.13% | -12.8% |
Q1 2020 | $24,019,000 | +57.8% | 896,551 | +80.4% | 0.15% | +82.7% |
Q4 2019 | $15,217,000 | +101.3% | 496,969 | +58.4% | 0.08% | +58.8% |
Q3 2019 | $7,558,000 | -4.9% | 313,725 | 0.0% | 0.05% | -5.6% |
Q2 2019 | $7,950,000 | +29.9% | 313,725 | 0.0% | 0.05% | +38.5% |
Q1 2019 | $6,118,000 | +136.6% | 313,725 | +60.0% | 0.04% | +85.7% |
Q4 2018 | $2,586,000 | -25.8% | 196,078 | 0.0% | 0.02% | -8.7% |
Q3 2018 | $3,486,000 | -19.2% | 196,078 | 0.0% | 0.02% | -28.1% |
Q2 2018 | $4,314,000 | – | 196,078 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |